Tysabri
Sponsors
Biogen, University at Buffalo, University of Chicago, Kessler Foundation
Conditions
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingProgressive Multifocal LeukoencephalopathyRelapsing-Remitting Multiple Sclerosis
Unknown Phase
Tysabri Observational Program
CompletedNCT00493298
Start: 2007-06-29End: 2023-11-01Updated: 2024-04-08
Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
CompletedNCT00937677
Start: 2007-11-30End: 2010-11-30Updated: 2011-09-07
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
CompletedNCT01071512
Start: 2010-04-30End: 2016-01-31Updated: 2017-10-25
Tysabri Observational Cohort Study - Multiple Sclerosis (MS) Registries
CompletedNCT03399981
Start: 2017-06-01End: 2023-12-31Updated: 2024-03-19
Examining Effects of Tysabri on Cognitive Fatigue Using fMRI
RecruitingNCT04565431
Start: 2021-03-19End: 2024-12-31Target: 25Updated: 2024-02-15
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
RecruitingNCT05658497
Start: 2023-10-27End: 2032-07-06Target: 908Updated: 2025-08-01